Precision oncology: 2024 in review Review

  


Authors: Repetto, M.; Fernandez, N.; Drilon, A.; Chakravarty, D.
Review Title: Precision oncology: 2024 in review
Abstract: Summary: This article discusses the specific advances made in precision oncology in 2024. We comment on the evolving nature of predictive molecular events used to select patients who will most benefit clinically from treatment. We also discuss advances in the development of strategic treatment regimens for combination thera-pies, rational drug design of small-molecule inhibitors, and structurally informed drug repurposing. © 2024 American Association for Cancer Research.
Keywords: gene mutation; genetics; cancer growth; neoplasm; neoplasms; biological marker; epidermal growth factor receptor; drug design; oncology; protein p53; artificial intelligence; medical oncology; drug therapy; b raf kinase; personalized medicine; growth inhibition; procedures; mapk signaling; humans; human; article; precision medicine; drug repositioning; personalized cancer therapy
Journal Title: Cancer Discovery
Volume: 14
Issue: 12
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2024-12-01
Start Page: 2332
End Page: 2345
Language: English
DOI: 10.1158/2159-8290.Cd-24-1476
PUBMED: 39618285
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211426010&doi=10.1158%2f2159-8290.CD-24-1476&partnerID=40&md5=754bb1094dc46d8d311df59ae85be1e5
Notes: Article -- MSK corresponding author is Debyani Chakravarty -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Debyani Chakravarty
    86 Chakravarty
  2. Alexander Edward Drilon
    633 Drilon
  3. Nicole B Fernandez
    8 Fernandez
  4. Matteo Repetto
    26 Repetto
Related MSK Work